| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.47 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |